About PrecisionLife
We're addressing one of the greatest challenges of our time – transforming healthcare to predict, treat, and prevent the world's most costly diseases

Chronic diseases are the biggest challenge facing global health
Billions of people live with debilitating chronic conditions that lack clear understanding of what causes them and how to accurately diagnose or effectively treat them – costing lives, wellbeing, and trillions of dollars to global economies.
PrecisionLife is here to change that.
Our mission is bold but simple:
To give every patient a faster, clearer path to better health – creating better, more personalized treatment options and diagnostic tools to reduce the global burden of chronic disease through precision medicine that works for everyone.
We use world-leading AI and the most advanced analytics platform on the planet to uncover the biological drivers of disease that are invisible to other data analysis models. Our platform reveals the unique mechanisms causing illness in individuals.
This means we're uniquely able to:
- Develop low-cost, non-invasive tests that can predict and diagnose diseases earlier and more accurately
- Help doctors match patients with the most effective treatments based on their personal biology
- Support pharmaceutical companies to develop better therapies and more successful clinical trials
- Identify the hidden biology that can actively protect people at risk of disease and prevents their onset
Our approach is groundbreaking.
We've already made progress in over 60 diseases across neuroscience, women's health, immunology & more – building the world’s largest databank of novel disease insights and working with partners across healthcare and biopharma to make precision medicine possible for all diseases – improving lives, increasing healthspan, and reducing the unsustainable burden on health systems.
"To truly understand, predict and prevent complex diseases, we must move beyond symptom-based labels and adopt a fundamentally mechanistic view of biology – just as we did to transform cancer care into precision medicine."
"PrecisionLife leads the world in identifying these mechanisms of disease and turning insights into clinically actionable solutions to reduce the global burden of chronic disease."

Steve Gardner, CEO of PrecisionLife

A new era of precision medicine
Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.
These differences cannot be understood by previous gold standard genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.
Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.
Until now...
Putting people at the center of their health
We've completely reimagined how to analyze patient data.
Using our Combinatorial Analytics & AI platform we are the first company able to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.
This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on biology.
Increasing success for clinical trials, treatments and patients.
-min%20(1).png)
World-leading science
10x signal from 10% of data
Our platform is world-leading – identifying causal biology, the holy grail of precision medicine, in over 60 complex diseases.
Improving global health
>5 Billion patients lives
Our clinical research studies have created new precision medicine opportunities for diseases that affect 5.4B people.
Proprietary disease insights
>100K protectable IP assets
We've created the most valuable repository of chronic disease insights, including biomarkers, risk models, and novel targets.
Rapid reduction to practice
Reducing the cost of healthcare
Our mechanostic tests identify disease risk for earlier, more personalized intervention and prevention of chronic diseases.